{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:02:36Z","timestamp":1792054956783,"version":"4.4.0"},"reference-count":279,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.bcp.2004.05.036","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T01:36:44Z","timestamp":1091151404000},"page":"1171-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections"],"prefix":"10.1016","volume":"68","author":[{"given":"Nathalie","family":"Dijsselbloem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vanden Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"De Naeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Haegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2004.05.036_BIB1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1360-1385(99)01471-5","article-title":"Flavonoids and isoflavonoids\u2014a gold mine for metabolic engineering","volume":"4","author":"Dixon","year":"1999","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2003-41122","article-title":"Phytoestrogens: recent developments","volume":"69","author":"Cos","year":"2003","journal-title":"Planta Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-8223(99)00051-6","article-title":"Characteristics and occurrence of phenolic phytochemicals","volume":"99","author":"King","year":"1999","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/01635589609514470","article-title":"Phytoestrogen content of foods\u2014a compendium of literature values","volume":"26","author":"Reinli","year":"1996","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2004.05.036_BIB6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-9422(02)00116-4","article-title":"Genistein","volume":"60","author":"Dixon","year":"2002","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bcp.2004.05.036_BIB7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1367-5931(98)80127-0","article-title":"Therapeutic potential of selective estrogen receptor modulators","volume":"2","author":"Gustafsson","year":"1998","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0165-6147(03)00229-3","article-title":"What pharmacologists can learn from recent advances in estrogen signalling","volume":"24","author":"Gustafsson","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00436-8","article-title":"Update on estrogen signaling","volume":"546","author":"Weihua","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2004.05.036_BIB10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1097-2765(02)00746-3","article-title":"A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains","volume":"10","author":"Metivier","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1570-0232(02)00340-9","article-title":"Phytoestrogens as modulators of steroid action in target cells","volume":"777","author":"Benassayag","year":"2002","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(02)00050-8","article-title":"The secrets of selective estrogen receptor modulation: cell-specific coregulation","volume":"1","author":"Jordan","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB13","first-page":"6619","article-title":"Molecular classification of estrogens","volume":"61","author":"Jordan","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB14","first-page":"4419","article-title":"Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor","volume":"62","author":"Levenson","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1677\/erc.0.0100517","article-title":"Estrogen receptor corepressors\u2014a role in human breast cancer?","volume":"10","author":"Dobrzycka","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(04)00054-1","article-title":"Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors","volume":"13","author":"Nettles","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB17","doi-asserted-by":"crossref","first-page":"17808","DOI":"10.1074\/jbc.M100953200","article-title":"Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens","volume":"276","author":"An","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB18","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB19","first-page":"1945","article-title":"Newly discovered estrogen receptor: new therapeutic possibilities in postmenopausal symptoms, osteoporosis, cancer of the breast and prostate","volume":"95","author":"Enmark","year":"1998","journal-title":"Lakartidningen"},{"key":"10.1016\/j.bcp.2004.05.036_BIB20","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1126\/science.1070442","article-title":"Biomedicine: defining the \u201cS\u201d in SERMs","volume":"295","author":"Katzenellenbogen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcp.2004.05.036_BIB21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/endo.140.2.6480","article-title":"Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta","volume":"140","author":"Sun","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB22","first-page":"359","article-title":"Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism","volume":"9","author":"Shiau","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1079\/PNS2001140","article-title":"Steroid hormone receptors and dietary ligands: a selected review","volume":"61","author":"Jacobs","year":"2002","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.54.1.105","article-title":"Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists\/antagonists","volume":"54","author":"Barkhem","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0960-0760(03)00034-7","article-title":"Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy","volume":"84","author":"Beck","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB26","doi-asserted-by":"crossref","first-page":"3811S","DOI":"10.1093\/jn\/133.11.3811S","article-title":"Isoflavone genistein: photoprotection and clinical implications in dermatology","volume":"133","author":"Wei","year":"2003","journal-title":"J Nutr"},{"issue":"Suppl. 9B","key":"10.1016\/j.bcp.2004.05.036_BIB27","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1016\/S0002-9343(01)00995-0","article-title":"Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer","volume":"113","author":"Kris-Etherton","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1389450033347000","article-title":"Phytoestrogens: pharmacological and therapeutic perspectives","volume":"4","author":"Bolego","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2004.05.036_BIB29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrg1047","article-title":"Nutrigenomics: goals and strategies","volume":"4","author":"Muller","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bcp.2004.05.036_BIB31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5122(02)00024-5","article-title":"The nature and utility of the phytoestrogens: a review of the evidence","volume":"42","author":"Albertazzi","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ptr.1364","article-title":"Phytoestrogens: a review of the present state of research","volume":"17","author":"Ososki","year":"2003","journal-title":"Phytother Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbrc.2003.08.090","article-title":"Oxidative modulation of NF-kappaB signaling by oxidized low-density lipoprotein","volume":"309","author":"Muroya","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2004.05.036_BIB34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1023483223842","article-title":"Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation","volume":"246","author":"Naderi","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10715769709097785","article-title":"Antioxidant activity of phytoestrogenic isoflavones","volume":"26","author":"Ruiz-Larrea","year":"1997","journal-title":"Free Radic Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB36","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/S0021-9258(18)45614-1","article-title":"Genistein, a specific inhibitor of tyrosine-specific protein kinases","volume":"262","author":"Akiyama","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0006-2952(01)00583-4","article-title":"Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1","volume":"61","author":"Casagrande","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB38","first-page":"1328","article-title":"Genistein arrests cell cycle progression at G2-M","volume":"53","author":"Matsukawa","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB39","first-page":"29","article-title":"Pleotropic effects of genistein on MCF-7 breast cancer cells","volume":"12","author":"Chinni","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB40","first-page":"2369","article-title":"Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway","volume":"8","author":"Li","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB41","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/sj.onc.1206583","article-title":"Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells","volume":"22","author":"Gong","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB42","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0959-8049(00)00017-4","article-title":"Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells","volume":"36","author":"Salti","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB43","first-page":"5111","article-title":"Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II","volume":"49","author":"Markovits","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0026-895X(24)26474-9","article-title":"Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins","volume":"57","author":"Nichols","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB45","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1081\/CNV-120023773","article-title":"Soy isoflavones and cancer prevention","volume":"21","author":"Sarkar","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB46","doi-asserted-by":"crossref","first-page":"439S","DOI":"10.1093\/ajcn\/70.3.439s","article-title":"Legumes and soybeans: overview of their nutritional profiles and health effects","volume":"70","author":"Messina","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/109662002760178131","article-title":"Dietary compounds in relation to dietary diversity and human health","volume":"5","author":"Hughes","year":"2002","journal-title":"J Med Food"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2004.05.036_BIB48","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0378-5122(02)00344-4","article-title":"Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?","volume":"44","author":"Wuttke","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB49","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1208\/ps050325","article-title":"Nutraceutical\u2014definition and introduction","volume":"5","author":"Kalra","year":"2003","journal-title":"AAPS Pharm Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB50","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/85.22.1819","article-title":"Migration patterns and breast cancer risk in Asian\u2013American women","volume":"85","author":"Ziegler","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2004.05.036_BIB51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1749-6632.2002.tb04117.x","article-title":"Diet and breast cancer","volume":"963","author":"Bradlow","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrc1298","article-title":"Diet and cancer\u2014the European prospective investigation into cancer and nutrition","volume":"4","author":"Bingham","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1570-0232(02)00213-1","article-title":"Flavonoids and steroid hormone-dependent cancers","volume":"777","author":"Rosenberg Zand","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB54","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/jnci\/51.5.1479","article-title":"Changing incidence of breast cancer in Japanese\u2013American women","volume":"51","author":"Buell","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2004.05.036_BIB55","doi-asserted-by":"crossref","first-page":"1705S","DOI":"10.1093\/ajcn\/71.6.1705S","article-title":"Protection against breast cancer with genistein: a component of soy","volume":"71","author":"Lamartiniere","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB56","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1996.118","article-title":"Menstrual and reproductive factors and risk of breast cancer in Asian\u2013Americans","volume":"73","author":"Wu","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB57","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/0277-5379(89)90373-8","article-title":"Cancers of the breast, endometrium and ovary: geographic correlations","volume":"25","author":"Parkin","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/50.1.21","article-title":"Etiology of human breast cancer: a review","volume":"50","author":"MacMahon","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2004.05.036_BIB59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jnci\/88.9.617","article-title":"Ethnic differences in estrogen metabolism in healthy women","volume":"88","author":"Taioli","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2004.05.036_BIB60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0163-7258(01)00137-1","article-title":"Dietary agents in cancer prevention: flavonoids and isoflavonoids","volume":"90","author":"Birt","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2004.05.036_BIB61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1470-2045(02)00777-5","article-title":"Phyto-oestrogens and cancer","volume":"3","author":"Adlercreutz","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jn\/128.2.209","article-title":"Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women","volume":"128","author":"Nagata","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB63","doi-asserted-by":"crossref","first-page":"1375S","DOI":"10.1093\/ajcn\/68.6.1375S","article-title":"Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women","volume":"68","author":"Potter","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB64","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ajcn\/72.3.844","article-title":"Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women","volume":"72","author":"Alekel","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5122(95)00899-V","article-title":"Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat","volume":"21","author":"Murkies","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB66","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/aje\/153.8.790","article-title":"Soy product intake and hot flashes in Japanese women: results from a community-based prospective study","volume":"153","author":"Nagata","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jn\/126.1.43","article-title":"Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys","volume":"126","author":"Anthony","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB68","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/archinte.159.17.2070","article-title":"A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins","volume":"159","author":"Crouse","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/01635589409514310","article-title":"Soy intake and cancer risk: a review of the in vitro and in vivo data","volume":"21","author":"Messina","year":"1994","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB70","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1073\/pnas.90.7.2690","article-title":"Genistein, a dietary-derived inhibitor of in vitro angiogenesis","volume":"90","author":"Fotsis","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2004.05.036_BIB71","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1093\/jn\/131.10.3186","article-title":"Soy isoflavones increase latency of spontaneous mammary tumors in mice","volume":"132","author":"Jin","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3181\/00379727-217-44245","article-title":"Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats","volume":"217","author":"Lamartiniere","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(96)09480-9","article-title":"Exposure of infants to phyto-oestrogens from soy-based infant formula","volume":"350","author":"Setchell","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2004.05.036_BIB74","first-page":"567","article-title":"Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus","volume":"4","author":"Colditz","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0960-0760(02)00273-X","article-title":"Phytoestrogens and breast cancer","volume":"83","author":"Adlercreutz","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB76","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1289\/ehp.02110917","article-title":"Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action","volume":"110","author":"Rajapakse","year":"2002","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.bcp.2004.05.036_BIB77","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1021\/es0101227","article-title":"Something from \u201cnothing\u201d\u2014eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects","volume":"36","author":"Silva","year":"2002","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0048-9697(98)00261-7","article-title":"Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles","volume":"221","author":"Kortenkamp","year":"1998","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.bcp.2004.05.036_BIB79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0048-9697(99)00228-4","article-title":"Approaches to assessing combination effects of oestrogenic environmental pollutants","volume":"233","author":"Kortenkamp","year":"1999","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.bcp.2004.05.036_BIB80","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0027-5107(01)00175-0","article-title":"Soy isoflavonoids and cancer\u2014metabolism at the target site","volume":"480\u2013481","author":"Boersma","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB81","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02976960","article-title":"Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response","volume":"26","author":"Kim","year":"2003","journal-title":"Arch Pharm Res"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2004.05.036_BIB82","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1079\/BJN2002796","article-title":"Bioavailability of phyto-oestrogens","volume":"89","author":"Rowland","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB83","doi-asserted-by":"crossref","first-page":"1453S","DOI":"10.1093\/ajcn\/68.6.1453S","article-title":"Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life","volume":"68","author":"Setchell","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB84","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1289\/ehp.95103346","article-title":"Environmental and dietary estrogens and human health: is there a problem?","volume":"103","author":"Safe","year":"1995","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.bcp.2004.05.036_BIB85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s001090050104","article-title":"Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications","volume":"75","author":"Kelce","year":"1997","journal-title":"J Mol Med"},{"issue":"Suppl. 7","key":"10.1016\/j.bcp.2004.05.036_BIB86","first-page":"103","article-title":"Phytoestrogens: epidemiology and a possible role in cancer protection","volume":"103","author":"Adlercreutz","year":"1995","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.bcp.2004.05.036_BIB87","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB88","first-page":"897","article-title":"A review of the clinical effects of phytoestrogens","volume":"87","author":"Knight","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB89","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB90","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00006254-200205000-00023","article-title":"Phytoestrogens in the management of the menopause: up-to-date","volume":"57","author":"Ewies","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bcp.2004.05.036_BIB91","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/JPEM.2002.15.5.561","article-title":"Phytoestrogens: a review of recent findings","volume":"15","author":"Stark","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.bcp.2004.05.036_BIB92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000441-200210000-00004","article-title":"Phytoestrogens: a viable option?","volume":"324","author":"Russell","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1210\/en.2003-0669","article-title":"Hypothalamic-pituitary cytokine network","volume":"145","author":"Kariagina","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB94","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of interleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.exger.2003.10.024","article-title":"In vivo visualization of aging-associated gene transcription: evidence for free radical theory of aging","volume":"39","author":"Zhang","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB99","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0006-2952(00)00412-3","article-title":"Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6","volume":"60","author":"Vanden Berghe","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB100","first-page":"4653","article-title":"Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB101","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/sj.onc.1206478","article-title":"Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways","volume":"22","author":"Park","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB102","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/0008-5472.CAN-03-3486","article-title":"Androgen receptor signaling: mechanism of interleukin-6 inhibition","volume":"64","author":"Jia","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB103","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","article-title":"Prognostic value of serum levels of interleukin-6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients","volume":"88","author":"Bachelot","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB104","first-page":"371","article-title":"The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells","volume":"49","author":"Honma","year":"2002","journal-title":"Endocrinol J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/bcr425","article-title":"The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer","volume":"4","author":"Purohit","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1359-6101(00)00021-6","article-title":"Interleukin-6 and prostate cancer progression","volume":"12","author":"Smith","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB107","first-page":"1773","article-title":"Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression","volume":"7","author":"Lin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB108","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-03-2517","article-title":"Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival","volume":"64","author":"Yamagiwa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pros.1080","article-title":"Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice","volume":"48","author":"Smith","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2004.05.036_BIB110","first-page":"1427","article-title":"Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma","volume":"19","author":"Zhang","year":"1999","journal-title":"AntiCancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB111","first-page":"8051","article-title":"Interleukin-6-174G\u2192C polymorphism is associated with improved outcome in high-risk breast cancer","volume":"63","author":"DeMichele","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bjc.6601545","article-title":"The \u2212174 G\/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype","volume":"90","author":"Iacopetta","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB113","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.10833","article-title":"Circulating interleukin-6 predicts survival in patients with metastatic breast cancer","volume":"103","author":"Salgado","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB114","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2004.05.036_BIB115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1015587423262","article-title":"Tumors and inflammatory infiltrates: friends or foes?","volume":"19","author":"Brigati","year":"2002","journal-title":"Clin Exp Metastas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB116","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB117","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB118","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1073\/pnas.1531903100","article-title":"Chronic stress and age-related increases in the proinflammatory cytokine IL-6","volume":"100","author":"Kiecolt-Glaser","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2004.05.036_BIB119","unstructured":"Lamberts SWJ. Endocrinology and aging. Williams Textbook of Endocrinology. 2002. p. 1287\u20131302."},{"key":"10.1016\/j.bcp.2004.05.036_BIB120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0145-305X(97)00029-3","article-title":"Immunologic aspects of osteoporosis","volume":"21","author":"Ershler","year":"1997","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.bcp.2004.05.036_BIB121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(02)00259-5","article-title":"Phytoestrogens for hormone replacement therapy?","volume":"83","author":"Wuttke","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB122","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells","year":"2002","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0960-0760(02)00258-3","article-title":"The menopause, hormone replacement therapy and breast cancer","volume":"83","author":"Marsden","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB124","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Cranney A, Griffith L, Walter S, Krolicki N, Favus M, Rosen C. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am 2002;31:659\u2013679, xii.","DOI":"10.1016\/S0889-8529(02)00024-5"},{"key":"10.1016\/j.bcp.2004.05.036_BIB125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2004.05.036_BIB126","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.291.14.1769","article-title":"The WHI estrogen-alone trial\u2014do things look any better?","volume":"291","author":"Hulley","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB127","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB128","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.291.13.1610","article-title":"Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review","volume":"291","author":"Nelson","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.288.3.368","article-title":"Estrogen replacement therapy and risk of ovarian cancer","volume":"288","author":"Noller","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bcp.2004.05.036_BIB130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2004.05.036_BIB131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc723","article-title":"Natural products in cancer chemotherapy: past, present and future","volume":"2","author":"Mann","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB132","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri887","article-title":"Nf-kappab, chemokine gene transcription and tumour growth","volume":"2","author":"Richmond","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB133","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB134","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","article-title":"A physical and functional map of the human TNF-alpha\/NF-kappaB signal transduction pathway","volume":"6","author":"Bouwmeester","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB136","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappaB and rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB137","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.onc.1206262","article-title":"Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference","volume":"22","author":"Zhou","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB138","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/rp.58.1.95","article-title":"Identification of a nuclear factor kappa B-dependent gene network","volume":"58","author":"Tian","year":"2003","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB139","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nri936","article-title":"Opinion: interpretation of the complexity of innate immune responses by functional genomics","volume":"2","author":"Ricciardi-Castagnoli","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI11891","article-title":"Series introduction: the transcription factor NF-kappaB and human disease","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB142","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1101\/gad.909001","article-title":"NF-kappaB signaling pathways in mammalian and insect innate immunity","volume":"15","author":"Silverman","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB143","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB144","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB146","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/sj.onc.1204535","article-title":"Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis","volume":"20","author":"Huang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB147","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/sj.onc.1205243","article-title":"Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells","volume":"21","author":"Bhat-Nakshatri","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB148","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB149","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","article-title":"To be, or not to be: NF-kappaB is the answer\u2014role of Rel\/NF-kappaB in the regulation of apoptosis","volume":"22","author":"Kucharczak","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00001622-200311000-00001","article-title":"Nuclear factor-kappaB as a predictor of treatment response in breast cancer","volume":"15","author":"Garg","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB151","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2004.05.036_BIB152","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrd987","article-title":"Knockouts model the 100 best-selling drugs\u2014will they model the next 100?","volume":"2","author":"Zambrowicz","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2004.05.036_BIB153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1568010023344706","article-title":"Upstream signal transduction of NF-kappaB activation","volume":"1","author":"Chen","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.bcp.2004.05.036_BIB154","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1359-6446(02)02309-7","article-title":"NF-kappa B: arresting a major culprit in cancer","volume":"7","author":"Haefner","year":"2002","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bcp.2004.05.036_BIB155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568026033392570","article-title":"Ethnobotany and natural products: the search for new molecules, new treatments of old diseases or a better understanding of indigenous cultures?","volume":"3","author":"Heinrich","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB156","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1471-4906(01)02044-0","article-title":"Inhibiting NF-kB","volume":"22","author":"O\u2019Neill","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB157","first-page":"233","article-title":"Induction and repression of NF-kB-driven inflammatory genes","volume":"40","author":"Vanden Berghe","year":"2002","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.bcp.2004.05.036_BIB158","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.193.12.1351","article-title":"Two waves of nuclear factor kappaB recruitment to target promoters","volume":"193","author":"Saccani","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB159","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni748","article-title":"p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment","volume":"3","author":"Saccani","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB160","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1101\/gad.232502","article-title":"Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes","volume":"16","author":"Saccani","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB161","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.immunol.20.100301.064739","article-title":"Chromatin structure and gene regulation in the immune system","volume":"20","author":"Smale","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB162","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20021039","article-title":"Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins","volume":"197","author":"Holloway","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB163","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/MCB.20.5.1596-1603.2000","article-title":"The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism","volume":"20","author":"Michael","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB164","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2002-09-2851","article-title":"Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites","volume":"101","author":"Goriely","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2004.05.036_BIB165","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB166","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0968-0004(00)01753-9","article-title":"I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations","volume":"26","author":"Schmitz","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB167","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(02)01196-0","article-title":"Signaling network model of chromatin","volume":"111","author":"Schreiber","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB168","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0968-0004(02)02207-7","article-title":"Multisite phosphorylation provides sophisticated regulation of transcription factors","volume":"27","author":"Holmberg","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB169","doi-asserted-by":"crossref","first-page":"3773S","DOI":"10.1093\/jn\/133.11.3773S","article-title":"Polyphenols, inflammatory response, and cancer prevention: chlorination of isoflavones by human neutrophils","volume":"133","author":"D\u2019Alessandro","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0027-5107(01)00183-X","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation","volume":"480\u2013481","author":"Surh","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB171","first-page":"372","article-title":"Dietary phytoestrogens have anti-inflammatory activity in a guinea pig model of asthma","volume":"223","author":"Regal","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB172","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00011-003-1182-8","article-title":"Genistein as an anti-inflammatory agent","volume":"52","author":"Verdrengh","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB173","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1164\/ajrccm.164.12.2104017","article-title":"Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide","volume":"164","author":"Kang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB174","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0006-2952(03)00415-5","article-title":"Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha","volume":"66","author":"Baxa","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB175","first-page":"1383","article-title":"Growth inhibition of human breast cancer cells by herbs and phytoestrogens","volume":"6","author":"Dixon-Shanies","year":"1999","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2004.05.036_BIB176","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1207\/S15327914NC352_11","article-title":"Genistein inhibits NF-kappa B activation in prostate cancer cells","volume":"35","author":"Davis","year":"1999","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB177","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/00006676-200405000-00020","article-title":"Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line","volume":"28","author":"Li","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB178","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00006676-200304000-00010","article-title":"Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid","volume":"26","author":"Buchler","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.bcp.2004.05.036_BIB179","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/endo.140.6.6763","article-title":"Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture","volume":"140","author":"Maret","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0303-7207(03)00255-7","article-title":"Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression","volume":"206","author":"Harrington","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB181","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0960-0760(98)00078-8","article-title":"The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner","volume":"67","author":"Cerillo","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB182","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/meta.2002.33352","article-title":"Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women","volume":"51","author":"Jenkins","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2004.05.036_BIB183","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/MCB.15.9.4971","article-title":"Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C\/EBP beta","volume":"15","author":"Stein","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB184","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(97)00487-0","article-title":"Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor","volume":"409","author":"Ray","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2004.05.036_BIB185","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/nar\/25.12.2424","article-title":"Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site","volume":"25","author":"Galien","year":"1997","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB186","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1006\/bbrc.1998.8324","article-title":"Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation","volume":"244","author":"Sun","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2004.05.036_BIB187","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/endo.141.9.7646","article-title":"The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells","volume":"141","author":"Harnish","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB188","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0960-0760(96)00175-6","article-title":"Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor","volume":"60","author":"Kurebayashi","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB189","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/hh2101.098543","article-title":"Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo","volume":"89","author":"Evans","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB190","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/endo.143.7.8919","article-title":"Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver","volume":"143","author":"Evans","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB191","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB192","doi-asserted-by":"crossref","first-page":"28181","DOI":"10.1074\/jbc.M303141200","article-title":"Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB","volume":"278","author":"Ruan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB193","first-page":"355","article-title":"A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids","volume":"12","author":"Wissink","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB194","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(00)00297-6","article-title":"Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors","volume":"109","author":"De Bosscher","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB195","doi-asserted-by":"crossref","first-page":"26267","DOI":"10.1074\/jbc.271.42.26267","article-title":"Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter","volume":"271","author":"Keller","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB196","doi-asserted-by":"crossref","first-page":"24151","DOI":"10.1074\/jbc.271.39.24151","article-title":"Mutual transcriptional interference between RelA and androgen receptor","volume":"271","author":"Palvimo","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB197","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1074\/jbc.271.11.6217","article-title":"Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor","volume":"271","author":"Kalkhoven","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB198","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/mend.12.1.0044","article-title":"Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism","volume":"12","author":"McKay","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB199","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1074\/jbc.274.1.510","article-title":"Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity","volume":"274","author":"Tian","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB200","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1074\/jbc.M213071200","article-title":"Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages","volume":"278","author":"Castrillo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1432-1033.1997.00063.x","article-title":"1alpha,25-Dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression","volume":"250","author":"Harant","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3: involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D\u2019Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB203","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1158\/0008-5472.CAN-03-3326","article-title":"Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells","volume":"64","author":"Frasor","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB204","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1074\/jbc.M209483200","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein","volume":"278","author":"Dang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1248\/bpb.26.532","article-title":"Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay","volume":"26","author":"Amakura","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2004.05.036_BIB206","first-page":"981","article-title":"Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors","volume":"1","author":"Suetsugi","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB207","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1043-2760(02)00634-3","article-title":"Estrogen action and cytoplasmic signaling pathways. Part II. The role of growth factors and phosphorylation in estrogen signaling","volume":"13","author":"Driggers","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2004.05.036_BIB208","first-page":"447S","article-title":"Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response","volume":"9","author":"Schiff","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB209","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2003.08.004","article-title":"Tyrosine kinase receptors as attractive targets of cancer therapy","volume":"50","author":"Bennasroune","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB210","first-page":"101","article-title":"Endocrine-responsive breast cancer and strategies for combating resistance","volume":"2","author":"Ali","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB211","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/j.1460-2075.1996.tb00571.x","article-title":"Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation","volume":"15","author":"Bunone","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB212","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2004.05.036_BIB213","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M010840200","article-title":"Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance","volume":"276","author":"Campbell","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB214","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjc.6601541","article-title":"Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function","volume":"90","author":"Bhat-Nakshatri","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB215","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0006-2952(02)01161-9","article-title":"Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit","volume":"64","author":"Vermeulen","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB216","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1043-2760(02)00633-1","article-title":"Estrogen action and cytoplasmic signaling cascades. Part I. Membrane-associated signaling complexes","volume":"13","author":"Segars","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2004.05.036_BIB217","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/sj.onc.1207332","article-title":"Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer","volume":"23","author":"Lu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB218","doi-asserted-by":"crossref","first-page":"27008","DOI":"10.1074\/jbc.M403588200","article-title":"The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells","volume":"279","author":"Maggiolini","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.036_BIB219","doi-asserted-by":"crossref","first-page":"36869","DOI":"10.1074\/jbc.R100029200","article-title":"The multifaceted mechanisms of estradiol and estrogen receptor signaling","volume":"276","author":"Hall","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.103.055038","article-title":"Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways","volume":"307","author":"Farach-Carson","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2004.05.036_BIB221","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrm1009","article-title":"Nongenomic actions of steroid hormones","volume":"4","author":"Losel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB222","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/13453","article-title":"Estrogen hits the surface","volume":"5","author":"Collins","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB223","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB224","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00190-X","article-title":"Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer","volume":"80","author":"Filardo","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB226","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb743","article-title":"A receptor for green tea polyphenol EGCG","volume":"11","author":"Tachibana","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB227","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0167-4889(95)00015-K","article-title":"Protein tyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes","volume":"1266","author":"Larner","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2004.05.036_BIB228","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB229","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-5793(97)00652-2","article-title":"Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase","volume":"410","author":"Darnay","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2004.05.036_BIB230","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.4049\/jimmunol.170.9.4767","article-title":"Tyrosine phosphorylation of I-kappa B kinase alpha\/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression","volume":"170","author":"Huang","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB231","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1074\/jbc.M208521200","article-title":"c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression","volume":"278","author":"Huang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB232","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB233","doi-asserted-by":"crossref","first-page":"L607","DOI":"10.1152\/ajplung.00116.2002","article-title":"Involvement of protein tyrosine kinase in toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB234","doi-asserted-by":"crossref","first-page":"25953","DOI":"10.1074\/jbc.M011021200","article-title":"Redox-sensitive transactivation of epidermal growth factor receptor by tumor necrosis factor confers the NF-kappa B activation","volume":"276","author":"Hirota","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-8981(03)00196-7","article-title":"The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2\/neu oncoprotein in Taiwanese patients with breast cancer","volume":"334","author":"Hou","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2004.05.036_BIB236","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/erc.0.0080161","article-title":"Receptor tyrosine kinase signalling as a target for cancer intervention strategies","volume":"8","author":"Zwick","year":"2001","journal-title":"Endocrinol Relat Cancer"},{"key":"10.1016\/j.bcp.2004.05.036_BIB237","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","article-title":"An open-and-shut case? Recent insights into the activation of EGF\/ErbB receptors","volume":"12","author":"Burgess","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2004.05.036_BIB238","first-page":"516S","article-title":"New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation","volume":"9","author":"Lee","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB239","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1038\/sj.onc.1204102","article-title":"From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents","volume":"19","author":"Morin","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-1119(03)00816-3","article-title":"Transcriptional regulation by the MAP kinase signaling cascades","volume":"320","author":"Yang","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB241","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.embor.embor854","article-title":"The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases","volume":"4","author":"Devin","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bcp.2004.05.036_BIB242","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2004.05.036_BIB243","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1038\/sj.onc.1204083","article-title":"Development of anticancer drugs targeting the MAP kinase pathway","volume":"19","author":"Sebolt-Leopold","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB244","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/j.1460-2075.1993.tb05978.x","article-title":"Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF","volume":"12","author":"Schulze-Osthoff","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB245","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/j.1460-2075.1991.tb07761.x","article-title":"Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1","volume":"10","author":"Schreck","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB246","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002030-199105000-00004","article-title":"Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives","volume":"5","author":"Mihm","year":"1991","journal-title":"Aids"},{"key":"10.1016\/j.bcp.2004.05.036_BIB247","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1038\/sj.onc.1203128","article-title":"Role of redox potential and reactive oxygen species in stress signaling","volume":"18","author":"Adler","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.036_BIB248","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB249","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1128\/jvi.66.11.6288-6293.1992","article-title":"Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein","volume":"66","author":"Schreck","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB250","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/emboj\/cdg332","article-title":"Evidence that reactive oxygen species do not mediate NF-kappaB activation","volume":"22","author":"Hayakawa","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB251","doi-asserted-by":"crossref","first-page":"13969","DOI":"10.1073\/pnas.232574399","article-title":"New careers for antioxidants","volume":"99","author":"Brash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2004.05.036_BIB252","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/cdg379","article-title":"NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death","volume":"22","author":"Sakon","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB253","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/1568026013394750","article-title":"Role of flavonoids in oxidative stress","volume":"1","author":"Cotelle","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB254","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/bcr562","article-title":"Expression profiling predicts outcome in breast cancer","volume":"5","author":"van\u2019t Veer","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB255","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van\u2019t Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.05.036_BIB256","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1152\/physiolgenomics.00107.2003","article-title":"Nutritional genomics: the next frontier in the postgenomic era","volume":"16","author":"Kaput","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.bcp.2004.05.036_BIB257","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjmed.2003.08.018","article-title":"Inflammation, hormones, and body composition at a crossroad","volume":"115","author":"Ferrucci","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.bcp.2004.05.036_BIB258","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1081\/ERC-120016992","article-title":"The adrenal hormone metabolism in the immune\/inflammatory reaction","volume":"28","author":"Bornstein","year":"2002","journal-title":"Endocrinol Res"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2004.05.036_BIB259","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2362.2000.0300s3091.x","article-title":"The role of interleukin-6 in the human adrenal gland","volume":"30","author":"Path","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bcp.2004.05.036_BIB260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb03142.x","article-title":"Hypothalamic\u2013pituitary\u2013adrenocortical and gonadal functions in rheumatoid arthritis","volume":"992","author":"Cutolo","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB261","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB262","doi-asserted-by":"crossref","first-page":"32091","DOI":"10.1074\/jbc.274.45.32091","article-title":"The nuclear factor-kappaB engages CBP\/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter","volume":"274","author":"Vanden Berghe","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.05.036_BIB263","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB264","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR","volume":"544","author":"Vanden Berghe","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB265","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0531-5565(02)00067-0","article-title":"Thymic sensitivity to hypoxic condition in young and old rats: age-dependent expression of NF-kappaB","volume":"37","author":"Trubiani","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB266","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/0008-5472.CAN-03-0005","article-title":"Involvement of Rel\/nuclear factor-kappaB transcription factors in keratinocyte senescence","volume":"64","author":"Bernard","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2004.05.036_BIB267","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1100\/tsw.2001.104","article-title":"Involvement of rel\/nf-B transcription factors in cellular senescence","volume":"1","author":"Bernard","year":"2001","journal-title":"Sci. World J"},{"key":"10.1016\/j.bcp.2004.05.036_BIB268","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/421686a","article-title":"Epigenetics and disease: altered states","volume":"421","author":"Dennis","year":"2003","journal-title":"Nature"},{"issue":"Suppl","key":"10.1016\/j.bcp.2004.05.036_BIB269","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2004.05.036_BIB270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0300-483X(03)00286-5","article-title":"The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma","volume":"194","author":"Calemine","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB271","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.2003.01704.x","article-title":"Influence of oestrogen receptor alpha and beta on the immune system in aged female mice","volume":"110","author":"Islander","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2004.05.036_BIB272","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0047-6374(03)00011-3","article-title":"Interrelationships among brain, endocrine and immune response in ageing and successful ageing: role of metallothionein III isoform","volume":"124","author":"Giacconi","year":"2003","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.bcp.2004.05.036_BIB273","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(02)00069-2","article-title":"Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males","volume":"164","author":"Barud","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2004.05.036_BIB274","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0531-5565(01)00202-9","article-title":"MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans","volume":"37","author":"Mocchegiani","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1043-2760(03)00051-1","article-title":"Hormonal regulation of aging and life span","volume":"14","author":"Brown-Borg","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2004.05.036_BIB276","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1521-6616(03)00203-1","article-title":"Age-related epigenetic changes and the immune system","volume":"109","author":"Issa","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bcp.2004.05.036_BIB277","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2004.05.036_BIB278","doi-asserted-by":"crossref","first-page":"570S","DOI":"10.1093\/ajcn\/78.3.570S","article-title":"Fruits and vegetables in the prevention of cellular oxidative damage","volume":"78","author":"Prior","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2004.05.036_BIB279","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0047-6374(00)00212-8","article-title":"Antioxidants may contribute in the fight against ageing: an in vitro model","volume":"121","author":"Hu","year":"2000","journal-title":"Mech Ageing Dev"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295204003752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295204003752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:01:14Z","timestamp":1762095674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295204003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":279,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0006295204003752"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2004.05.036","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2004.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}